Literature DB >> 16909432

In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice.

Dirk Baumjohann1, Andreas Hess, Lubos Budinsky, Kay Brune, Gerold Schuler, Manfred B Lutz.   

Abstract

Dendritic cell (DC) migration into the draining lymph nodes is critical for T cell priming. Here, we show that magnetic resonance imaging (MRI) can be used to visualize DC migration in vivo. We combined clinically approved small particles of iron oxide (SPIO) with protamine sulfate to achieve efficient uptake by murine bone marrow-derived DC. SPIO-DC were largely unaltered and after injection into the footpads of mice, they migrated into the T cell areas of the draining lymph nodes, which could be visualized by MRI. Distinct MRI signal reduction patterns correlated with the detection of SPIO-DC mainly within Thy-1.2+ B220- T cell areas, as confirmed by iron staining and immunohistology. Clear signal reduction patterns could still be observed with 1x10(6) injected SPIO-DC at high resolution, resulting in the detection of about 2000 DC. Control injections of homing-incompetent SPIO-DC derived from CCR7-/- mice or SPIO alone did not reach the T cell areas. Taken together, the results demonstrate that clinically approved contrast agents allow the non-invasive visualization of DC migration into the draining lymph node by MRI in vivo at high resolution. This protocol therefore also allows dynamic imaging of immune responses and MRI-based tracking of human DC in patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909432     DOI: 10.1002/eji.200535742

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

1.  In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles.

Authors:  Roja Rohani; Sonali N de Chickera; Christy Willert; Yuhua Chen; Gregory A Dekaban; Paula J Foster
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

2.  Magnetic nanoparticles for imaging dendritic cells.

Authors:  Saho Kobukai; Richard Baheza; Jared G Cobb; Jack Virostko; Jingping Xie; Amelie Gillman; Dmitry Koktysh; Denny Kerns; Mark Does; John C Gore; Wellington Pham
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

Review 3.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

4.  A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging.

Authors:  Chih-Lung Chen; Haosen Zhang; Qing Ye; Wen-Yuan Hsieh; T Kevin Hitchens; Hsin-Hsin Shen; Li Liu; Yi-Jen Wu; Lesley M Foley; Shian-Jy Wang; Chien Ho
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

Review 5.  In vivo tracking of cellular therapeutics using magnetic resonance imaging.

Authors:  Christoper M Long; Jeff W M Bulte
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

Review 6.  The Immunoimaging Toolbox.

Authors:  Aaron T Mayer; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2018-05-24       Impact factor: 10.057

Review 7.  Experimental models to investigate the function of dendritic cell subsets: challenges and implications.

Authors:  D G Hancock; T V Guy; E Shklovskaya; B Fazekas de St Groth
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

Review 8.  Tracking immune cells in vivo using magnetic resonance imaging.

Authors:  Eric T Ahrens; Jeff W M Bulte
Journal:  Nat Rev Immunol       Date:  2013-09-10       Impact factor: 53.106

9.  CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells.

Authors:  Alice W Yewdall; Scott B Drutman; Felecia Jinwala; Keith S Bahjat; Nina Bhardwaj
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

10.  Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.

Authors:  Christopher M Long; Hanneke W M van Laarhoven; Jeff W M Bulte; Hyam I Levitsky
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.